Alfacalcidol Vs. Calcidol for Secondary Hyperparathyroidism - Renal and Urology News

Links shared publicly online about this topic.

1,640
total visits

Alfacalcidol Vs. Calcidol for Secondary Hyperparathyroidism - Renal and Urology News

Oral alfacalcidol is effective in controlling secondary hyperparathyroidism with an adjusted dose 1.5 times that of oral calcitriol, a study showed. In a randomized, single-blinded controlled trial, researchers in Thailand studied 32 hemodialysis patients with secondary hyperparathyroidism whom they stratified according to HD frequency and parathyroid hormone (PTH) levels and randomized to receive either calcitriol or alfacalcidol in a dose-escalating fashion for up to 24 weeks.

View full resource at renalandurologynews.com

Tags: Hormone, Parathyroid Disorder, Kidney Health, Urinary System, Dialysis, Urology, News